Loss of Heterozygosity at the NAD(P)H:Quinone Oxidoreductase Locus Associated with Increased Resistance against Mitomycin C in a Human Bladder Carcinoma Cell Line

Biological Chemistry Hoppe-Seyler

Volumn 375, Issue 7, 1994, Pages 439-446

  Eickelmann, Peter ^a   Schulz, Wolfgang A ^a   Sies, Helmut ^a   Rohde, Detlef ^b   Schmitz Drager, Bernd ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Chromosome 16; Drug metabolism; DT diaphorase; Null allele; PCR; RFLP; RT112

Indexed keywords

MITOMYCIN; PRIMER DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE);

ARTICLE; BLADDER TUMOR; CELL CULTURE; CELL DIVISION; CHROMOSOME DELETION; DRUG RESISTANCE; ENZYMOLOGY; GENETICS; HETEROZYGOTE; HUMAN; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY;

BASE SEQUENCE; BLADDER NEOPLASMS; CELL DIVISION; CHROMOSOME DELETION; DNA PRIMERS; DRUG RESISTANCE; HETEROZYGOTE; HUMAN; MITOMYCIN; MOLECULAR SEQUENCE DATA; QUINONE REDUCTASES; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028467127     PISSN: 01773593     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/bchm3.1994.375.7.439     Document Type: Article

References (38)

1. Begleiter, A., Robotham, E., and Leith, M.K. (1992). Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia. Mol. Pharmacol. 41,677-682.
2. Begleiter, A., and Leith, M.K. (1993). Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions. Mol. Pharmacol. 44, 210–215.
3. Benson, A.M., Hunkeler, M.J., and Talalay, P. (1980). Increase of NAD(P)H:quinone reductase by dietary antioxidants: Possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA 77,5216-5220.
4. Bradford, M.M. (1976). A rapid and sensitive method for the quan-titation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72,248-254.
5. Chomczynski, P., and Sacci, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloro-form extraction. Anal. Biochem. 162,156-159.
6. Crooke, S.T., and Bradner, W.T. (1976). Mitomycin C: a review. Cancer Treat. Rev. 3,121-139.
7. Dulhanty, A.M., and Whitmore, G.F. (1991). Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not under hypoxic conditions are deficient in DT-diaphorase. Cancer Res. 51,1860-1865.
8. Edwards, Y.H., Potter, J., and Hopkinson, D.A. (1980). Human FAD dependent NAD(P)H diaphorase. Biochem. J. 187,429-436.
9. Eickelmann, P., Ebert, T., Warskulat, U., Schulz, W.A., and Sies, H. (1994). Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases in human renal cell carcinoma and in kidney cancer derived cell lines. Carcinogenesis 15, 219–225.
10. Fisher, G.R., Patterson, L.H., and Gutierrez, P.L. (1993). A comparison of free radical formation by quinone antitumor agents in MCF-7 cells and the role of NAD(P)H:(quinone-acceptor) oxidoreductase (DT-diaphorase). Chem. Biol. Interactions 88, 137–153.
11. Gustafson, D.L., and Pritsos, C.A. (1992). Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicumarol. Cancer Res. 52,6936-6939.
12. Habig, W.H., Pabst, M.J., and Jacoby, W.B. (1974). Glutathione S-transferases the first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249,7130-7139.
13. Herr, H.W. (1987). Intravesical therapy, a critical review. Urol. Clin. North Am. 14,399-404.
14. Horikoshi, T., Danenberg, K.D., Stadlbauer, T.H.W., Volkenandt, M., Shea, L.C.C., Aigner, K., Gustavsson, B., Leichman, L., Frosing, R., Ray, M., Gibson, N.W., Spears, C.P., and Danenberg, P.V. (1992). Quantitation of thymidylate synthase, dihyd-rofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res. 52,108-116.
15. Jaiswal, A.K. (1991). Human NAD(P)H:quinone oxidoreductase (NQ01) gene structure and induction by dioxin. Biochemistry 30,10647-10653.
16. Jaiswal, A.K., McBride, O.W., Adesnik, M., and Nebert, D.W. (1988). Human dioxin-inducible NAD(P)H: menadione oxidoreductase. J. Biol. Chem. 263,13572-13578.
17. Kappus, H., and Sies, H. (1981). Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia 37,1233-1241.
18. Klone, A., Hussnatter, R., and Sies, H. (1992). Cloning, sequencing and characterization of the human alpha glutathione S-transferase gene corresponding to the cDNA clone pGTH2. Biochem. J. 285, 925–928.
19. Klone, A., Weidner, U., Hussnatter, R., Harris, J., Meyer, D., Peter, S., Ketterer, B., and Sies, H. (1990). Decreased expression of the glutathione S-transferases alpha and pi genes in human renal cell carcinoma. Carcinogenesis 11,2179-2183.
20. Ma, Q., Cui, K., Xiao, F., Lu, A.Y.H., and Yang, C.S. (1992a). Identification of a glycine-rich sequence as an NAD(P)H-binding site and tyrosine 128 as a dicumarol-binding site in rat liver NAD(P)H:quinone oxidoreductase by site-directed mutagenesis. J. Biol. Chem. 267,22298-22304.
21. Ma, Q., Cui, K., Wang, R.W., Lu, A.Y.H., and Yang, C.S. (1992b). Site-directed mutagenesis of rat liver NAD(P)H:quinone oxidoreductase: roles of lysine 76 and cysteine 179. Arch. Biochem. Biophys. 294,434-439.
22. Malkinson, A.M., Siegel, D., Forrest, G.L., Gazdar, A.F., Oie, H.K., Chan, D.C., Bunn, P.A., Mabry, M., Dykes, D.J., Harrison, S.D., and Ross, D. (1992). Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res. 52,4752-4757.
23. Marshall, R.S., Paterson, M.C., and Rauth, A.M. (1989). Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br. J. Cancer 59, 341–346.
24. Marshall, R.S., Paterson, M.C., and Rauth, A.M. (1991a). DT-diaphorase activity and mitomycin C sensitivity in non-trans-formed cell strains derived from members of a cancer prone family. Carcinogenesis, 12,1175-1180.
25. Marshall, R.S., Paterson, M.C., and Rauth, A.M. (1991b). Studies on the mechanism of resistance to mitomycin C and porfiromy-cin in a human cell strain derived from a cancer-prone individual. Biochem. Pharmacol. 41,1351-1360.
26. Masters, J., Hepburn, P.J., Walker, L. Highman, W.J., Trejdosie-wicz, L.K., Povey, S., Pavkar, M., Hill, B.T., Riddle, P.R., and Franks, L.M. (1986). Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res. 46,3630-3636.
27. Nishiyama, M., Saeki, S., Aogi, K., Hirabayashi, N., and Toge. T. (1993). Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: differences in vitro and in vivo systems. Int. J. Cancer 53,1013-1016.
28. Perry, R.R., Kang, Y., and Greaves, B. (1993). Biochemical characterization of a mitomycin C resistant colon cancer cell line variant. Biochem. Pharmacol. 46,1999-2005.
29. Pinkel, D., Landegent, J., Collins, C., Fuscoe, J., Segraves, R., Lucas, J., and Gray, J. (1986). Fluorescence ISH with human chromosome specific libraries: Detection of trisomy 21 and translocation of chromosome 4. Proc. Natl. Acad. Sci. USA 85,9138-9142.
30. Pritsos, C.A., Pardini, L.L., Elliott, A.J., and Pardini, R.S. (1988). Relationship between the antioxidant enzyme DT-diaphorase and tumor response to mitomycin C treatment. Basic Life Sciences 49,713-716.
31. Sakiyama, S., Nakumura, Y.,Tokunaga, K.,Takazawa, H., Ohkawi, Y., and Nagano, T. (1989). Stage specific localization of cyto-skeletal actin mRNA in murine seminiferous tubules and intestinal epithelia as demonstrated by in situ hybridization. Cell Tissue Res. 258,225-231.
32. Schmittgen, T.D., Wientjes, M.G., Badalement, R.A., and Au, J.L.S. (1991). Pharmacodynamics of mitomycin C in cultured human bladder tumors. Cancer Res. 51,3849-3856.
33. Schulz, W.A., and Gais, G. (1989). Constitutive c-myc expression enhances proliferation of differentiating F9 teratocarcinoma cells. Biochim. Biophys. Acta 1013,125-132.
34. Siegel, D., Beall, H., Senekowitsch, C., Kasai, M., Arai, H., Gibson, N.W., and Ross, D. (1992). Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry, 31,7879-7885.
35. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S., and Boyd, M.R., (1990). New colorimetric assay for anticancer-drug screening. J. Natl. Cancer Inst. 82,1107-1112.
36. Traver, R.D., Horikoshi, T., Danenberg, K.D., Stadlbauer, T.H.W., Danenberg, P.V., Ross, D., and Gibson, N.W. (1992). NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin C sensitivity. Cancer Res. 52,797-802.
37. Tso, J.Y., Sun, X.H., Kao, T.H., Reece, K.S., and Wu, R. (1985). Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic and molecular evolution of the gene. Nucleic Acids Res. 13,2485-2502.
38. Xu, B.H., Gupta, V., and Singh, S.V. (1994). Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Arch. Biochem. Biophys. 308,164-170.